Tag Archives: Hologic

Healthcare Sector Roundup: Hologic (NASDAQ:HOLX), Insulet (NASDAQ:PODD) – HOLX, PODD, JNJ, AVEO, CYTK, GALE

Posted on May 7, 2013 by Thomas Vedder

Investors responded negatively to the healthcare stocks on Monday. Key movement were observed in AVEO Pharmaceuticals, Inc (NASDAQ:AVEO) and Cytokinetics, Inc (NASDAQ:CYTK) on percentage gainers side while Galena Biopharma Inc (NASDAQ:GALE) was prominent stock on percentage gainer side.

Hologic, Inc …

Posted in Healthcare, Latest Headlines | Tagged AVEO, AVEO Pharmaceuticals, CYTK, Cytokinetics, GALE, Galena Biopharma, Hologic, HOLX, Insulet, JNJ, Johnson, NASDAQ:AVEO, NASDAQ:CYTK, NASDAQ:GALE, NASDAQ:HOLX, NASDAQ:PODD, NYSE:JNJ, PODD | Comments Off

Healthcare Sector Snapshot: Thermo Fisher (NYSE:TMO), Life Technologies (NASDAQ:LIFE) – TMO, LIFE, HOLX, ROCM, STAA, THRX

Posted on April 16, 2013 by Thomas Vedder

Healthcare sector finished lower on Monday as well as whole market finished in red land. Key movement were observed at Rochester Medical Corporation (NASDAQ:ROCM) and STAAR Surgical Company (NASDAQ:STAA) on percentage decliners side while key gainer was Theravance Inc (NASDAQ:THRX).…

Posted in Healthcare, Latest Headlines | Tagged Hologic, HOLX, LIFE, Life Technologies, NASDAQ:HOLX, NASDAQ:LIFE, NASDAQ:ROCM, NASDAQ:STAA, NASDAQ:THRX, NYSE:TMO, Rochester Medical, ROCM, STAA, STAAR Surgical, Theravance, Thermo Fisher Scientific, THRX, TMO | Comments Off

Analogic (NASDAQ:ALOG) Reports Net Income Hikes in First Quarter

Posted on December 8, 2012 by Thomas Vedder

Analogic Corporation (NASDAQ:ALOG) announced Q1 GAAP net income of $4.4 million or $0.35 a share, evaluated against $4.0 million or $0.32 a share in the similar period a year ago.

The company reported that non-GAAP net income for the Q1 …

Posted in Main Post, Technology | Tagged ALOG, Analogic, Arrhythmia Research, Hologic, HOLX, HRT, NASDAQ:ALOG, NASDAQ:HOLX, NYSE:SMA, NYSEAMEX:HRT, SMA, Symmetry Medical | Comments Off

Acadia Healthcare (NASDAQ:ACHC) Unveils 9.6 Million Share Offering to Fund Acquisitions – ACHC, UHS, FB, PFE, GALE, JNJ, HOLX, PPHM, DVAX

Posted on December 4, 2012 by Geoff Noir

Acadia Healthcare Company Inc (NASDAQ:ACHC) has announced a 9.6 million share offering as the company looks to raise proceeds to support purchases.

The behavioral-health services company will offer 6 million shares, while the rest will be offered by certain selling …

Posted in Healthcare, Latest Headlines | Tagged Acadia Healthcare, ACHC, DVAX, Dynavax, Facebook, FB, GALE, Galena, Hologic, HOLX, JNJ, Johnson, NASDAQ:ACHC, NASDAQ:DVAX, NASDAQ:FB, NASDAQ:GALE, NASDAQ:HOLX, NASDAQ:PPHM, NYSE:JNJ, NYSE:PFE, NYSE:UHS, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM, UHS, Universal Health Services | Comments Off

Health Care Sector Round Up; Hologic (HOLX) Posts Fourth Quarter Results while Gilead Sciences (GILD) Soars to All Time High Level – HOLX, GILD, JNJ, IDIX, NKTR

Posted on November 13, 2012 by Geoff Noir

Investors reacted positively to the healthcare stocks on Monday. Major movement were seen in Gilead Sciences, Inc (NASDAQ:GILD) and Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) on gainers side while Nektar Therapeutics (NASDAQ:NKTR) was most active stock on the decliners side.

Hologic, Inc …

Posted in Healthcare, Latest Headlines | Tagged GILD, Gilead Sciences, Hologic, HOLX, Idenix, IDIX, JNJ, Johnson, NASDAQ:GILD, NASDAQ:HOLX, NASDAQ:IDIX, NASDAQ:NKTR, Nektar Therapeutics, NKTR, NYSE:JNJ | Comments Off

Analogic (NASDAQ:ALOG) Soars to Record High after Topping Fourth Quarter Results – ALOG, OSIS, TMO, HOLX

Posted on September 17, 2012 by Thomas Vedder

Analogic Corporation (NASDAQ:ALOG) stock moved up to an all-time high on Friday after the corporation announced strong fiscal Q4 outcomes.

The medical imaging and security equipment company Analogic reported its net income over doubled to 96 cents a share in …

Posted in Latest Headlines, Technology | Tagged ALOG, Analogic, Hologic, HOLX, NASDAQ:ALOG, NASDAQ:HOLX, NASDAQ:OSIS, NYSE:TMO, OSI, OSIS, Thermo Fisher, TMO | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.